Comparison of myocardial tissue Doppler with transmitral flow Doppler in left ventricular hypertrophy

T Z Naqvi1, G Neyman, A Broyde

  • 1Cardiac Non-Invasive Laboratory, Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center and UCLA School of Medicine, Los Angeles, Calif 90048, USA. tasneem.naqvi@cshs.org

Insights

Myocardial Doppler measurements, including isovolumetric relaxation time and A-wave duration, are more sensitive than mitral inflow Doppler for detecting diastolic dysfunction in patients with left ventricular hypertrophy. These findings aid in assessing cardiac health.

Area of Science:

  • Cardiology
  • Echocardiography
  • Diastolic Function Assessment

Background:

  • Left ventricular hypertrophy (LVH) can impair diastolic function, even with normal systolic function.
  • Accurate assessment of diastolic dysfunction is crucial for managing patients with LVH.

Purpose of the Study:

  • To identify the most effective echocardiographic measurements for assessing diastolic function in patients with LVH and normal systolic function.
  • To compare the utility of myocardial Doppler velocities versus mitral inflow Doppler parameters.

Main Methods:

  • Echocardiographic assessment of diastolic function using myocardial Doppler and mitral inflow pulsed wave Doppler.
  • Comparison of measurements in healthy volunteers, patients without LVH, and patients with LVH.

Main Results:

  • Myocardial A-wave duration and isovolumetric relaxation time were significantly increased in patients with LVH.
  • Myocardial E-wave velocity was significantly decreased in patients with LVH.
  • Myocardial isovolumetric relaxation time and A-wave duration showed the strongest correlation with posterior wall thickness on multivariate analysis.

Conclusions:

  • Myocardial Doppler parameters, specifically isovolumetric relaxation time and A-wave duration, are more sensitive than mitral Doppler inflow parameters for detecting abnormal left ventricular relaxation in LVH.
  • These myocardial Doppler measurements are valuable tools for assessing diastolic function in this patient population.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...